SVA
Sinovac Biotech, Ltd.

760
Mkt Cap
$460.27M
Volume
0.00
52W High
$6.47
52W Low
$6.47
Price
$6.47
SVA Fundamentals
Prev Close
$6.49
Open
$6.47
50D MA
$6.47
Beta
0.00
Avg. Volume
0.00
Loading...
Loading...
News
all
press releases
SINOVAC Announces Nasdaq Hearings Panel Grants Continued Listing
Sinovac Biotech Ltd. (Nasdaq: SVA) (SINOVAC or the Company), a leading provider of biopharmaceutical products in China, today announced that the Nasdaq Hearings Panel (the Panel) has granted the...
Business Wire·18d ago
News Placeholder
More News
News Placeholder
Sinovac Biotech Updates Antigua Court Order On Board Composition
(RTTNews) - Sinovac Biotech Ltd. (SVA) announced an update on the Antigua High Court's interlocutory order regarding the Company's board composition and corporate actions pending trial. The Company...
Nasdaq News: Markets·1mo ago
News Placeholder
SINOVAC Provides Update on Antigua High Court Order and Auditor Engagement
Sinovac Biotech Ltd. (NASDAQ: SVA) (SINOVAC or the Company), a leading provider of biopharmaceutical products in China, today provided an update on the Antigua High Courts interlocutory order...
Business Wire·1mo ago
News Placeholder
Sinovac Receives Nasdaq Notification Regarding Late Filing of 2025 Half-Year Report
Sinovac Biotech Ltd. (NASDAQ: SVA) (SINOVAC or the Company), a leading provider of biopharmaceutical products in China, today announced that it has received a notification letter dated January 2...
Business Wire·1mo ago
News Placeholder
Sinovac:Antigua Court Makes Interim Order Giving Board Control of the Company until the Trial of the Disputed 2025 Shareholder Meeting
Sinovac Biotech Ltd. (NASDAQ: SVA) (SINOVAC or the Company), a leading provider of biopharmaceutical products in China, today announced that the Antigua High Court has ordered that the directors Mr...
Business Wire·2mo ago
News Placeholder
SINOVAC Announces Receipt of Nasdaq Notice of Delisting and Intention to Appeal
Sinovac Biotech Ltd. (Nasdaq: SVA) (SINOVAC or the Company), a leading provider of biopharmaceutical products in China, announced today that on November 12, 2025, it received a delisting...
Business Wire·3mo ago
News Placeholder
Independent Sinovac Shareholders Express Strong Support for Immediate Dividend Payment
Independent Sinovac Shareholders Express Strong Support for Immediate Dividend Payment Independent Sinovac Shareholders Express Strong Support for Immediate Dividend Payment PR Newswire BOSTON, Nov...
PR Newswire·3mo ago
News Placeholder
Sinovac Clears Legal Hurdle In Control Battle, Moves Forward With $55 Dividend
A U.S. court denied an emergency injunction sought by dissenting investors, while a separate case in Antigua could unlock an additional $11 per share if disputed PIPE shares are invalidated.
Stocktwits·8mo ago
<
...
1
>

Latest SVA News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.